Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial
- PMID: 28520672
- PMCID: PMC5593759
- DOI: 10.1097/HTR.0000000000000322
Sertraline for Major Depression During the Year Following Traumatic Brain Injury: A Randomized Controlled Trial
Abstract
Objective: Major depressive disorder (MDD) is common and associated with impaired functioning after traumatic brain injury (TBI). Few placebo-controlled antidepressant trials exist in this population. We evaluated the efficacy and tolerability of sertraline for MDD within 1 year of sustaining a TBI.
Setting: Level I trauma center.
Participants: Adults with MDD within 1 year of hospitalization for complicated mild to severe TBI.
Design: Randomized, double-blind, placebo-controlled trial.
Main measures: Twelve-week treatment response on the 17-item Hamilton Depression Rating Scale. We also assessed symptom improvement and remission.
Results: We randomized 62 participants: 32% sustained a severe TBI, 68% had significant anxiety, 63% had a history of prior MDD, and 69% had a history of alcohol or drug dependence. Depression significantly improved from baseline to 12 weeks in both treatment groups (P < .001). There were no significant differences between the sertraline and placebo groups over 12 weeks on depression severity, response, or remission. The sertraline group had significant improvement on speed of information processing compared with the placebo group (P < .006).
Conclusion: Sertraline monotherapy was not superior to placebo for MDD in people with post-acute complicated mild to severe TBI. Research is needed on the effectiveness of interventions that also address the significant psychosocial needs of this population.
Conflict of interest statement
No other disclosures were reported.
Figures
Similar articles
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.Arch Phys Med Rehabil. 2009 May;90(5):733-40. doi: 10.1016/j.apmr.2008.11.005. Arch Phys Med Rehabil. 2009. PMID: 19406291 Clinical Trial.
-
Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db. J Clin Psychopharmacol. 2011. PMID: 21869699 Clinical Trial.
-
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu. J Clin Psychiatry. 2010. PMID: 20193645 Clinical Trial.
-
Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.Int J Clin Pract. 2007 Aug;61(8):1337-48. doi: 10.1111/j.1742-1241.2007.01444.x. Int J Clin Pract. 2007. PMID: 17627710 Review.
Cited by
-
Effects of Repetitive Mild Traumatic Brain Injury on Corticotropin-Releasing Factor Modulation of Lateral Habenula Excitability and Motivated Behavior.bioRxiv [Preprint]. 2024 May 14:2024.04.16.589760. doi: 10.1101/2024.04.16.589760. bioRxiv. 2024. Update in: J Neurotrauma. 2024 Jul 18. doi: 10.1089/neu.2024.0184. PMID: 38798343 Free PMC article. Updated. Preprint.
-
Smoking blunts sertraline response in depression: A prospective observational cohort study.Med J Armed Forces India. 2024 Mar-Apr;80(2):145-152. doi: 10.1016/j.mjafi.2021.10.015. Epub 2022 Jan 10. Med J Armed Forces India. 2024. PMID: 38525466
-
Strain in the Midbrain: Impact of Traumatic Brain Injury on the Central Serotonin System.Brain Sci. 2024 Jan 5;14(1):51. doi: 10.3390/brainsci14010051. Brain Sci. 2024. PMID: 38248266 Free PMC article. Review.
-
Depression in Patients With Intracranial Hemorrhage Secondary to Traumatic Brain Injury.Cureus. 2023 Jul 19;15(7):e42147. doi: 10.7759/cureus.42147. eCollection 2023 Jul. Cureus. 2023. PMID: 37602011 Free PMC article.
-
Psychiatric sequelae of traumatic brain injury - future directions in research.Nat Rev Neurol. 2023 Sep;19(9):556-571. doi: 10.1038/s41582-023-00853-8. Epub 2023 Aug 17. Nat Rev Neurol. 2023. PMID: 37591931 Review.
References
-
- Hart T, Fann JR, Chervoneva I, et al. Prevalence, Risk Factors, and Correlates of Anxiety at 1 Year After Moderate to Severe Traumatic Brain Injury. Arch Phys Med Rehabil. 2016;97(5):701–707. - PubMed
-
- Fann JR, Katon WJ, Uomoto JM, Esselman PC. Psychiatric disorders and functional disability in outpatients with traumatic brain injuries. Am J Psychiatry. 1995;152(10):1493–1499. - PubMed
-
- Ashman TA, Cantor JB, Gordon WA, et al. A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury. Arch Phys Med Rehabil. 2009;90(5):733–740. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical